Valuation: Ion Beam Applications, SA

Market Cap 447M 510M 421M 384M 718M 48.83B 724M 5.05B 1.96B 24.89B 1.91B 1.87B 80.71B P/E 2026 *
19.1x
P/E 2027 * 13.8x
Enterprise Value 494M 563M 465M 425M 794M 53.93B 799M 5.58B 2.16B 27.5B 2.11B 2.07B 89.15B EV / Sales 2026 *
0.78x
EV / Sales 2027 * 0.7x
Free-Float
60.41%
Yield 2026 *
1.95%
Yield 2027 * 2.21%
1 day-5.41%
1 week-5.41%
Current month-5.44%
1 month-5.82%
3 months-9.33%
6 months+10.31%
Current year+14.70%
1 week 17.5
Extreme 17.5
17.5
1 month 17.5
Extreme 17.5
19.5
Current year 15
Extreme 15
20.1
1 year 11.45
Extreme 11.45
20.1
3 years 8.65
Extreme 8.65
20.1
5 years 8.65
Extreme 8.65
20.95
10 years 6.34
Extreme 6.34
61.6
Manager TitleAgeSince
Chief Executive Officer 58 01/05/2012
Chief Tech/Sci/R&D Officer 78 28/03/1986
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 65 01/05/2013
Director/Board Member 78 01/05/1991
Director/Board Member 58 01/05/2012
Change 5-day change 1-year change 3-year change Capi.($)
-5.41%-5.41% - - 510M
+1.03%+2.60%+41.63%+32.32% 246B
+0.21%+6.34%+16.78%-10.79% 156B
-0.94%+4.19%-11.04%+38.20% 141B
-0.67%+1.62%-54.32%-16.75% 64.66B
-2.21%-2.76%+16.43%+24.63% 50.04B
+0.58%-2.68%-19.47%-20.87% 47.18B
-1.16%+7.57%+31.27%+48.39% 46.61B
-1.21%+0.46%+40.56%+56.35% 41.32B
+3.20%+11.55%+157.00%+92.83% 38.56B
Average -0.78%+3.56%+24.31%+27.14% 92.31B
Weighted average by Cap. -0.47%+3.64%+20.31%+22.84%

Financials

2026 *2027 *
Net sales 633M 722M 595M 544M 1.02B 69.13B 1.02B 7.15B 2.77B 35.25B 2.71B 2.65B 114B 643M 732M 604M 552M 1.03B 70.14B 1.04B 7.26B 2.81B 35.76B 2.75B 2.69B 116B
Net income 22.82M 26M 21.45M 19.62M 36.65M 2.49B 36.93M 258M 99.9M 1.27B 97.65M 95.51M 4.12B 32.74M 37.31M 30.78M 28.14M 52.59M 3.57B 52.98M 370M 143M 1.82B 140M 137M 5.91B
Net Debt 46.78M 53.3M 43.98M 40.21M 75.13M 5.11B 75.69M 528M 205M 2.6B 200M 196M 8.44B 3.88M 4.42M 3.64M 3.33M 6.23M 423M 6.27M 43.77M 16.97M 216M 16.59M 16.22M 699M
Logo Ion Beam Applications, SA
Ion Beam Applications, SA (IBA) is gespecialiseerd in het ontwerp, de vervaardiging en de verkoop van apparatuur voor de diagnose en de behandeling van kanker. De omzet (voor binnen de groep afgestoten activiteiten) per productfamilie wordt als volgt onderverdeeld: - apparatuur en systemen voor diagnose en therapeutische behandeling (89,4%): apparatuur voor protontherapie (59,8% van de omzet; wereldwijd n° 1), deeltjesversnellers (40,2%) gebruikt voor de productie van radio-isotopen (cyclotrons) en voor de ontwikkeling van sterilisatie- en ionisatieoplossingen (Rhodotron®); - dosimetrie-apparatuur en -oplossingen (10,6%; wereldwijd nr. 1): meet- en analyse-instrumenten voor de doses van straling en radiotherapie en medische beeldvorming. De geografische verdeling van de omzet is als volgt: België (2,3%), Verenigde Staten (34%), China (11,6%), Duitsland (6,5%), India (5,8%) en andere (39,8%).
Employees
2,264
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
15.38EUR
Average target price
17.62EUR
Spread / Average Target
+14.60%

Annual profits - Rate of surprise